IMM 1.59% 31.0¢ immutep limited

abagovomab fails placebo phase111 trial, page-19

  1. 2,649 Posts.
    lightbulb Created with Sketch. 249
    Hi abdm

    I agree all posts containing facts and interesting observations on both sides of the argument are very welcome.

    However, while I agree that traders may well be 'informed' (you'd hope so) it is inaccurate to imagine that TA traders are 'objective' in the sense that they are 'disinterested'.

    On the contrary, TA traders have a contingent interest in all the shares they track and they naturally prefer volatilty, from which good traders make more money.

    At least the 'abagovomab vs Cvac' thread is finished.
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
31.0¢
Change
-0.005(1.59%)
Mkt cap ! $450.9M
Open High Low Value Volume
31.5¢ 31.8¢ 31.0¢ $897.5K 2.872M

Buyers (Bids)

No. Vol. Price($)
9 79201 31.0¢
 

Sellers (Offers)

Price($) Vol. No.
31.5¢ 138883 3
View Market Depth
Last trade - 16.10pm 08/10/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.